COGT (Cogent Biosciences) Other Current Liabilities: $8.05 Mil (As of Mar. 2026)


COGT Cogent Biosciences Inc COGT
25 GF Score
Price $38.72
! 4 Warning Signs
View Full Analysis

What is Cogent Biosciences Other Current Liabilities?

Cogent Biosciences COGT +0.55% 25 Other Current Liabilities is $8.05 Mil as of Mar. 2026. GuruFocus rates COGT with a GF Score™ of 25/100. The stock has 4 warning signs investors should review.

Cogent Biosciences's other current liabilities for the quarter that ended in Mar. 2026 was $8.05 Mil.

Cogent Biosciences's quarterly other current liabilities increased from Sep. 2025 ($11.78 Mil) to Dec. 2025 ($22.49 Mil) but then declined from Dec. 2025 ($22.49 Mil) to Mar. 2026 ($8.05 Mil).

Cogent Biosciences's annual other current liabilities increased from Dec. 2023 ($10.32 Mil) to Dec. 2024 ($12.63 Mil) and increased from Dec. 2024 ($12.63 Mil) to Dec. 2025 ($22.49 Mil).

Cogent Biosciences Other Current Liabilities Related Terms

Cogent Biosciences Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Cogent Biosciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cogent Biosciences Other Current Liabilities Chart

Cogent Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.62 8.17 10.32 12.63 22.49

Cogent Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.15 9.40 11.78 22.49 8.05
COGT
25GF Score
Cogent Biosciences Inc COGT
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogent Biosciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $8.05 Mil mean?
Cogent Biosciences (COGT) has a Other Current Liabilities of $8.05 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Cogent Biosciences.
Is Cogent Biosciences' Other Current Liabilities too high?
Cogent Biosciences' current Other Current Liabilities is $8.05 Mil. Overall, Cogent Biosciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Cogent Biosciences' Other Current Liabilities compare to SRRK and CGON?
Cogent Biosciences' Other Current Liabilities of $8.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Cogent Biosciences. Cogent Biosciences's current Other Current Liabilities is $8.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogent Biosciences stock overvalued right now?
Cogent Biosciences (COGT) has a current Other Current Liabilities of $8.05 Mil. The current Other Current Liabilities is $8.05 Mil. Cogent Biosciences' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Cogent Biosciences (COGT), the current Other Current Liabilities is $8.05 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cogent Biosciences Business Description

Address 275 Wyman Street, 3rd Floor, Waltham, MA, USA, 02451
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
25GF Score

Get the complete analysis for COGT

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$38.72
Price